2.3 Bone Cells, the Remodeling Cycle, and Calcium Homeostasis

2.3 Bone Cells, the Remodeling Cycle, and Calcium Homeostasis

Quick Answer: The human skeleton comprises two structural compartments: Cortical bone (80% of skeletal mass, slow turnover ~2–3%/year, long bone shafts) and Trabecular bone (20% of mass, 80% of surface area, rapid turnover ~20–30%/year, vertebral bodies and metaphyses). Remodeling is carried out by the Basic Multicellular Unit (BMU) across five phases: Activation, Resorption (osteoclasts, 2–4 weeks), Reversal (coupling, 1–2 weeks), Formation (osteoblasts secreting osteoid, 3–4 months), and Mineralization/Quiescence. Calcium homeostasis is regulated by parathyroid hormone (PTH, drives resorption via RANKL and activates calcitriol), calcitonin (inhibits osteoclasts), and 1,25-dihydroxyvitamin D (enhances active intestinal calcium absorption).

Macro- and Micro-Architecture: Cortical vs. Trabecular Bone

The adult skeleton consists of approximately 206 bones divided into two structural compartments:

Cortical (Compact) Bone

Cortical bone constitutes approximately 80% of total adult skeletal mass, but only about 20% of skeletal surface area.

• Anatomical Distribution: Dominates the appendicular skeleton, forming the dense protective outer shell of all bones and the thick diaphyseal shafts of long bones (e.g., mid-femur and 33% radius).
• Microscopic Organization: Organized into cylindrical osteons (Haversian systems). Each osteon features a central longitudinal Haversian canal enclosing neurovascular capillaries, surrounded by concentric lamellae of calcified collagen. Transverse Volkmann canals connect adjacent Haversian canals to periosteal and endosteal surfaces.
• Turnover and Biomechanics: Exhibits a slow turnover rate of 2% to 3% per year. Cortical bone provides mechanical stiffness, torsional rigidity, and bending resistance.

Trabecular (Cancellous or Spongy) Bone

Trabecular bone accounts for roughly 20% of skeletal mass, yet provides nearly 80% of total metabolic surface area.

• Anatomical Distribution: Concentrated in the axial skeleton (lumbar vertebral bodies, pelvis, sacrum) and long bone metaphyses/epiphyses (proximal femur, trochanter, and ultra-distal radius).
• Microscopic Organization: Non-Haversian, porous 3D lattice of interconnected plates and struts called trabeculae (100–200 micrometers thick). Nutrients and hormones diffuse directly from marrow sinusoids across the endosteum through canaliculi.
• Turnover and Clinical Significance: Remodels rapidly at 20% to 30% per year—roughly 4 to 8 times faster than cortical bone. Due to its expansive surface area and high turnover, trabecular bone responds earliest to acute estrogen withdrawal, metabolic shifts, and therapies. Consequently, DXA scans of the posteroanterior (PA) lumbar spine (>65% trabecular) show earlier diagnostic changes and monitoring responses than cortical sites.

The Cellular Triad: Osteoclasts, Osteoblasts, and Osteocytes

Bone remodeling is carried out by three primary cellular effectors:

• Osteoclasts (Bone Resorption): Derived from hematopoietic stem cells (monocyte-macrophage lineage) stimulated by M-CSF and RANKL. Giant multinucleated cells (4 to 20 nuclei) expressing tartrate-resistant acid phosphatase (TRAP). Osteoclasts attach to bone via $\alpha_v\beta_3$ integrins, forming a sealed microenvironment with an extensive ruffled border. Vacuolar $ ext{H}^+$-ATPases actively pump hydrogen ions (pH 4.0–4.5) to dissolve hydroxyapatite crystals. Lysosomal cathepsin K then digests type I collagen, excavating a Howship's lacuna (trabecular) or cutting cone (cortical).
• Osteoblasts (Bone Formation): Derived from multipotent mesenchymal stem cells (MSCs) guided by Runx2 and Osterix. Cuboidal mononucleated cells that align along active bone surfaces to secrete osteoid (90% type I collagen, 10% non-collagenous proteins like osteocalcin). Osteoblasts express bone-specific alkaline phosphatase (BSAP), which hydrolyzes pyrophosphate inhibitors to promote calcium hydroxyapatite [$\text{Ca}_{10}(\text{PO}_4)_6(\text{OH})_2$] crystallization. Afterward, 60%–80% undergo apoptosis; the remainder differentiate into osteocytes or bone lining cells.
• Osteocytes (Mechanosensation and Regulation): Mature osteoblasts entombed within mineralized matrix inside lacunae. Represent >90% to 95% of all bone cells in the adult skeleton, living for decades. Osteocytes extend dendritic processes through fluid-filled canaliculi, forming an interconnected syncytium. Fluid shear stress triggers mechanotransductive signaling. In resting bone, osteocytes produce sclerostin (encoded by SOST), which binds LRP5/6 receptors on osteoblasts to inhibit Wnt/$\beta$-catenin bone formation. Mechanical loading downregulates sclerostin, unleashing Wnt signaling and osteoblast activity. Osteocytes also secrete RANKL and OPG.

The Bone Remodeling Cycle: Basic Multicellular Unit (BMU)

Remodeling occurs in localized focal units carried out by the Basic Multicellular Unit (BMU) across five coordinated stages:

1. Activation: Lining cells retract. Microdamage or altered strain triggers osteocyte apoptosis and RANKL release, recruiting pre-osteoclasts from the circulation and marrow.
2. Resorption: Mature osteoclasts adhere to bone, acidify the lacuna, and secrete cathepsin K to dissolve mineral and matrix. Duration: 2 to 4 weeks.
3. Reversal: Osteoclasts undergo apoptosis. Macrophage-like reversal cells clean the lacunar floor and deposit a cement line. Matrix growth factors (TGF-$\beta$, IGF-1) act as coupling signals recruiting pre-osteoblasts. Duration: 1 to 2 weeks.
4. Formation: Differentiated osteoblasts align in the lacuna and secrete unmineralized osteoid matrix in successive lamellae. Duration: 3 to 4 months.
5. Mineralization & Quiescence: Primary mineralization deposits ~70% of mineral within weeks; secondary mineralization consolidates over several months. Osteoblasts become osteocytes or lining cells, and the surface enters a quiescent resting state.

Endocrine Regulation of Calcium Homeostasis

Systemic ionized calcium is tightly defended within narrow limits (8.5–10.5 mg/dL total; 4.6–5.3 mg/dL ionized) via three primary hormones:

• Parathyroid Hormone (PTH): Secreted by parathyroid chief cells in response to low ionized calcium detected by CaSR. Actions: 1) Stimulates renal calcium reabsorption and phosphate excretion; 2) Upregulates renal 1-alpha-hydroxylase to synthesize calcitriol; 3) Stimulates bone resorption indirectly by binding to osteoblast and osteocyte receptors, increasing RANKL and decreasing OPG to activate osteoclasts. Continuous PTH elevation induces net bone loss; intermittent pulsatile PTH (teriparatide) stimulates osteoblast bone formation.
• Calcitonin: Synthesized by thyroid parafollicular C-cells in response to hypercalcemia. Binds directly to osteoclasts, causing rapid retraction of their ruffled borders and inhibiting bone resorption.
• 1,25-Dihydroxyvitamin D [Calcitriol / $1,25(\text{OH})_2\text{D}$]: Formed via hepatic 25-hydroxylation to $25(\text{OH}) ext{D}$ and renal 1-alpha-hydroxylation to $1,25(\text{OH})_2\text{D}$. Calcitriol stimulates active transcellular intestinal absorption of calcium (via TRPV6 and calbindin-D9k) and phosphorus in the duodenum and jejunum.